Venetoclax and Navitoclax in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

被引:3
|
作者
Alexander, Thomas [1 ]
Lacayo, Norman J. [2 ]
Pullarkat, Vinod A. [3 ]
Jabbour, Elias J. [4 ]
Khaw, Seong Lin [5 ]
Mullighan, Charles G. [6 ,7 ]
Bajel, Ashish [8 ]
Leonard, Jessica [9 ]
Norris, Robin [10 ]
Rubnitz, Jeffrey [11 ]
Vear, Susan I. [12 ]
Schmidt, Michelle [13 ]
Tong, Bo [13 ]
Zhou, Ying [13 ]
Ross, Jeremy A. [13 ]
Rosenwinkel, Lindsey [13 ]
Jacobson, Amanda [13 ]
Kim, Su Young [13 ]
Stock, Wendy [14 ]
机构
[1] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA
[2] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA
[3] City Hope Natl Med Ctr, Dept Hematol HCT, 1500 E Duarte Rd, Duarte, CA 91010 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[5] Royal Childrens Hosp, Melbourne, Vic, Australia
[6] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN USA
[7] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA
[8] Royal Melbourne Hosp, Melbourne, Vic, Australia
[9] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97201 USA
[10] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA
[11] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA
[12] Nationwide Childrens Hosp, Pediat Hematol & Oncol, Columbus, OH USA
[13] AbbVie Inc, N Chicago, IL USA
[14] Univ Chicago, Dept Med, Sect Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA
关键词
D O I
10.1182/blood-2018-99-113464
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3966
引用
收藏
页数:4
相关论文
共 50 条
  • [41] A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia
    Al-Kali, Aref
    Aldoss, Ibrahim
    Atherton, Pamela J.
    Strand, Carrie A.
    Shah, Bijal
    Webster, Jonathan
    Bhatnagar, Bhavana
    Flatten, Karen S.
    Peterson, Kevin L.
    Schneider, Paula A.
    Buhrow, Sarah A.
    Kong, Jianping
    Reid, Joel M.
    Adjei, Alex A.
    Kaufmann, Scott H.
    CANCER MEDICINE, 2023, 12 (23): : 21229 - 21239
  • [42] Current therapy and novel agents for relapsed or refractory acute lymphoblastic leukemia
    Dinner, Shira
    Lee, Daniel
    Liedtke, Michaela
    LEUKEMIA & LYMPHOMA, 2014, 55 (08) : 1715 - 1724
  • [43] Daratumumab for relapsed/refractory Philadelphia-positive acute lymphoblastic leukemia
    Ganzel, Chezi
    Kharit, Mira
    Duksin, Chen
    Rowe, Jacob M.
    HAEMATOLOGICA, 2018, 103 (10) : E489 - E490
  • [44] Efficacy and Toxicity of Inotuzumab in a Patient with Relapsed/ Refractory Acute Lymphoblastic Leukemia
    Giagnuolo, G.
    Petruzziello, F.
    Maisto, G.
    D'Amico, M. R.
    Ripaldi, M.
    Loffredo, G.
    Buffardi, S.
    Menna, G.
    Parasole, R.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S176 - S176
  • [45] Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia Current and Emerging Treatments
    Martin, Alissa
    Morgan, Elaine
    Hijiya, Nobuko
    PEDIATRIC DRUGS, 2012, 14 (06) : 377 - 387
  • [46] Role of inotuzumab ozogamicin in the treatment of relapsed/refractory acute lymphoblastic leukemia
    George, Binsah
    Kantarjian, Hagop
    Jabbour, Elias
    Jain, Nitin
    IMMUNOTHERAPY, 2016, 8 (02) : 135 - 143
  • [47] Bortezomib Combined Chemotherapy for Children with Relapsed/refractory Acute Lymphoblastic Leukemia
    Sakaguchi, Hirotoshi
    Maemura, Ryo
    Yamamori, Ayako
    Wakamatsu, Manabu
    Yoshida, Nao
    Kato, Koji
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S89 - S90
  • [48] Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomibbased chemotherapy
    Zhao, Junmei
    Wang, Chao
    Song, Yongping
    Liu, Yuzhang
    Fang, Baijun
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2015, 8 : 211 - 214
  • [49] Trial initiated for liposomal vincristine in relapsed/refractory acute lymphoblastic leukemia
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (10): : 1292 - 1292
  • [50] Modeling Relapsed, Refractory Acute Lymphoblastic Leukemia from a Child with Neurofibromatosis
    Heatley, Susan L.
    Page, Elyse C.
    Eadie, Laura N.
    McClure, Barbara J.
    Rehn, Jacqueline
    Yeung, David T.
    Osborn, Michael Philip
    Revesz, Tamas
    Kirby, Maria
    White, Deborah L.
    BLOOD, 2021, 138